Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-03

Clinical Trial Update: Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion and posted results of a Phase 1/2 clinical trial evaluating sodium phenylbutyrate in pre-symptomatic infants with spinal musc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium phenylbutyrate (sodium phenylbutyrate)

Snippet

Sponsor: University of Utah | Conditions: Spinal Muscular Atrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-07-03